O-GlcNAc a sensor of cellular state: The role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress

Biochimica et Biophysica Acta - General Subjects

Volumn 1673, Issue 1-2, 2004, Pages 13-28

  Zachara, Natasha E ^a   Hart, Gerald W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BAG; benzyl GalNAc; C terminal domain; casein kinase II; CK II; CTD; endothelial nitric oxide synthase; eNOS; ER; ERK; estrogen receptor; Heat shock; Hyperglycemia; N acetylglucosamine; O GlcNAc; Phosphorylation; Post translational modification; Stress

Indexed keywords

6 DIAZO 5 OXONORLEUCINE; AZASERINE; CYTOPLASM PROTEIN; FRUCTOSE 1,6 PHOSPHATE AMIDOTRANSFERASE; GLUCOSE DERIVATIVE; MONOSACCHARIDE; MORPHOGEN; O BETA N ACETYLGLUCOSAMINIDASE; O LINKED BETA N ACETYLGLUCOSAMINE; O PHOSPHATE; PHOSPHORUS DERIVATIVE; PROTEASOME; SERINE; THREONINE; UNCLASSIFIED DRUG; URIDINE DERIVATIVE; URIDINE DIPHOSPHATE ACETYLGLUCOSAMINE:POLYPEPTIDE O BETA N ACETYLGLUCOSAMINYLTRANSFERASE;

APOPTOSIS; BIOSENSOR; CELL CYCLE; CELL FUNCTION; CELL MATURATION; CYTOPLASM; ENZYME REGULATION; HUMAN; HYPERGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; NUTRIENT SUPPLY; OBESITY; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; STRESS;

ACETYLGLUCOSAMINE; ACETYLGLUCOSAMINIDASE; ANIMALS; BETA-N-ACETYLHEXOSAMINIDASE; CELL DEATH; CELL NUCLEUS; CYTOPLASM; DIABETES MELLITUS, TYPE 2; GLUCOSE; GLYCOSYLATION; HISTONE ACETYLTRANSFERASES; HUMANS; MULTIENZYME COMPLEXES; NUTRITION PHYSIOLOGY; PHOSPHORYLATION; PROTEINS; SIGNAL TRANSDUCTION; STRESS;

METAZOA;

EID: 3042613480     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2004.03.016     Document Type: Review

References (232)

1. Torres C.R., Hart G.W. Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. J. Biol. Chem. 259:1984;3308-3317
2. Holt G.D., Hart G.W. The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc. J. Biol. Chem. 261:1986;8049-8057
3. Holt G.D., Snow C.M., Senior A., Haltiwanger R.S., Gerace L., Hart G.W. Nuclear pore complex glycoproteins contain cytoplasmically disposed O-linked N-acetylglucosamine. J. Cell. Biol. 104:1987;1157-1164
4. Davis L.I., Blobel G. Nuclear pore complex contains a family of glycoproteins that includes p62: glycosylation through a previously unidentified cellular pathway. Proc. Natl. Acad. Sci. U. S. A. 84:1987;7552-7556
5. Hanover J.A., Cohen C.K., Willingham M.C., Park M.K. O-linked N-acetylglucosamine is attached to proteins of the nuclear pore. Evidence for cytoplasmic and nucleoplasmic glycoproteins. J. Biol. Chem. 262:1987;9887-9894
6. Kelly W.G., Hart G.W. Glycosylation of chromosomal proteins: localization of O-linked N-acetylglucosamine in Drosophila chromatin. Cell. 57:1989;243-251
7. Vosseller K., Sakabe K., Wells L., Hart G.W. Diverse regulation of protein function by O-GlcNAc: a nuclear and cytoplasmic carbohydrate post-translational modification. Curr. Opin. Chem. Biol. 6:2002;851-857
8. Wells L., Vosseller K., Cole R.N., Cronshaw J.M., Matunis M.J., Hart G.W. Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications. Mol. Cell. Proteomics. 1:2002;791-804
9. Zachara N.E., Hart G.W. The emerging significance of O-GlcNAc in cellular regulation. Chem. Rev. 102:2002;431-438
10. Wells L., Vosseller K., Hart G.W. Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science. 291:2001;2376-2378
11. Chou C.F., Omary M.B. Mitotic arrest-associated enhancement of O-linked glycosylation and phosphorylation of human keratins 8 and 18. J. Biol. Chem. 268:1993;4465-4472
12. Chou C.F., Smith A.J., Omary M.B. Characterization and dynamics of O-linked glycosylation of human cytokeratin 8 and 18. J. Biol. Chem. 267:1992;3901-3906
13. Kearse K.P., Hart G.W. Lymphocyte activation induces rapid changes in nuclear and cytoplasmic glycoproteins. Proc. Natl. Acad. Sci. U. S. A. 88:1991;1701-1705
14. Slawson C., Shafii S., Amburgey J., Potter R. Characterization of the O-GlcNAc protein modification in Xenopus laevis oocyte during oogenesis and progesterone-stimulated maturation. Biochim. Biophys. Acta. 1573:2002;121-129
15. Kamemura K., Hayes B.K., Comer F.I., Hart G.W. Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: alternative glycosylation/phosphorylation of THR-58, a known mutational hot spot of c-Myc in lymphomas, is regulated by mitogens. J. Biol. Chem. 277:2002;19229-19235
16. Walgren J.L., Vincent T.S., Schey K.L., Buse M.G. High glucose and insulin promote O-GlcNAc modification of proteins, including alpha-tubulin. Am. J. Physiol.: Endocrinol. Metab. 284:2003;E424-E434
17. Ku N.O., Omary M.B. Expression, glycosylation, and phosphorylation of human keratins 8 and 18 in insect cells. Exp. Cell Res. 211:1994;24-35
18. Roquemore E.P., Chevrier M.R., Cotter R.J., Hart G.W. Dynamic O-GlcNAcylation of the small heat shock protein alpha B-crystallin. Biochemistry. 35:1996;3578-3586
19. Dong D.L., Hart G.W. Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol. J. Biol. Chem. 269:1994;19321-19330
20. Favreau C., Worman H.J., Wozniak R.W., Frappier T., Courvalin J.C. Cell cycle-dependent phosphorylation of nucleoporins and nuclear pore membrane protein Gp210. Biochemistry. 35:1996;8035-8044
21. Du X.L., Edelstein D., Dimmeler S., Ju Q., Sui C., Brownlee M. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J. Clin. Invest. 108:2001;1341-1348
22. Federici M., Menghini R., Mauriello A., Hribal M.L., Ferrelli F., Lauro D., Sbraccia P., Spagnoli L.G., Sesti G., Lauro R. Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. Circulation. 106:2002;466-472
23. Parker G.J., Lund K.C., Taylor R.P., McClain D.A. Insulin resistance of glycogen synthase mediated by O-linked N-acetylglucosamine. J. Biol. Chem. 278:2003;10022-10027
24. Han I., Roos M.D., Kudlow J.E. Interaction of the transcription factor Sp1 with the nuclear pore protein p62 requires the C-terminal domain of p62. J. Cell. Biochem. 68:1998;50-61
25. Roos M.D., Su K., Baker J.R., Kudlow J.E. O-glycosylation of an Sp1-derived peptide blocks known Sp1 protein interactions. Mol. Cell. Biol. 17:1997;6472-6480
26. Yang X., Su K., Roos M.D., Chang Q., Paterson A.J., Kudlow J.E. O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc. Natl. Acad. Sci. U. S. A. 98:2001;6611-6616
27. Gao Y., Miyazaki J., Hart G.W. The transcription factor PDX-1 is post-translationally modified by O-linked N-acetylglucosamine and this modification is correlated with its DNA binding activity and insulin secretion in min6 beta-cells. Arch. Biochem. Biophys. 415:2003;155-163
28. Duverger E., Carpentier V., Roche A.C., Monsigny M. Sugar-dependent nuclear import of glycoconjugates from the cytosol. Exp. Cell Res. 207:1993;197-201
29. Duverger E., Pellerin-Mendes C., Mayer R., Roche A.C., Monsigny M. Nuclear import of glycoconjugates is distinct from the classical NLS pathway. J. Cell. Sci. 108(Pt. 4):1995;1325-1332
30. Duverger E., Roche A.C., Monsigny M. N-acetylglucosamine-dependent nuclear import of neoglycoproteins. Glycobiology. 6:1996;381-386
31. Monsigny M., Midoux P., Mayer R., Roche A.C. Glycotargeting: influence of the sugar moiety on both the uptake and the intracellular trafficking of nucleic acid carried by glycosylated polymers. Biosci. Rep. 19:1999;125-132
32. Soulard M., Della Valle V., Siomi M.C., Pinol-Roma S., Codogno P., Bauvy C., Bellini M., Lacroix J.C., Monod G., Dreyfuss G., et al. hnRNP G: sequence and characterization of a glycosylated RNA-binding protein. Nucleic Acids Res. 21:1993;4210-4217
33. Bachmann M., Pfeifer K., Schroder H.C., Muller W.E. The La antigen shuttles between the nucleus and the cytoplasm in CV-1 cells. Mol. Cell. Biochem. 85:1989;103-114
34. Juang Y.T., Solomou E.E., Rellahan B., Tsokos G.C. Phosphorylation and O-linked glycosylation of Elf-1 leads to its translocation to the nucleus and binding to the promoter of the TCR zeta-chain. J. Immunol. 168:2002;2865-2871
35. Chakraborty A., Saha D., Bose A., Hileman R.E., Chatterjee M., Gupta N.K. Mechanism of action of an eukaryotic initiation factor-2 (eIF-2) associated 67 kDa glycoprotein (p67) and an eIF-2 kinase (dsI). Indian J. Biochem. Biophys. 31:1994;236-242
36. Datta B., Ray M.K., Chakrabarti D., Wylie D.E., Gupta N.K. Glycosylation of eukaryotic peptide chain initiation factor 2 (eIF-2)-associated 67-kDa polypeptide (p67) and its possible role in the inhibition of eIF-2 kinase-catalyzed phosphorylation of the eIF-2 alpha-subunit. J. Biol. Chem. 264:1989;20620-20624
37. Ray M.K., Datta B., Chakraborty A., Chattopadhyay A., Meza-Keuthen S., Gupta N.K. The eukaryotic initiation factor 2-associated 67-kDa polypeptide (p67) plays a critical role in regulation of protein synthesis initiation in animal cells. Proc. Natl. Acad. Sci. U. S. A. 89:1992;539-543
38. Han I., Kudlow J.E. Reduced O-glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol. Cell. Biol. 17:1997;2550-2558
39. Cheng X., Cole R.N., Zaia J., Hart G.W. Alternative O-glycosylation/O- phosphorylation of the murine estrogen receptor beta. Biochemistry. 39:2000;11609-11620
40. Lefebvre T., Cieniewski C., Lemoine J., Guerardel Y., Leroy Y., Zanetta J.P., Michalski J.C. Identification of N-acetyl-D-glucosamine-specific lectins from rat liver cytosolic and nuclear compartments as heat-shock proteins. Biochem. J. 360:2001;179-188
41. Felin M., Doyennette-Moyne M.A., Hadj-Sahraoui Y., Aubery M., Hubert J., Seve A.P. Identification of two nuclear N-acetylglucosamine-binding proteins. J. Cell. Biochem. 56:1994;527-535
42. Botti J., Musset M., Moutsita R., Aubery M., Derappe C. Two laminin receptors with N-acetylglucosamine-binding specificity. Biochimie. 85:2003;231-239
43. Ravindranath R.M., Moradian-Oldak J., Fincham A.G. Tyrosyl motif in amelogenins binds N-acetyl-D-glucosamine. J. Biol. Chem. 274:1999;2464-2471
44. Pawson T., Scott J.D. Signaling through scaffold, anchoring, and adaptor proteins. Science. 278:1997;2075-2080
45. Yaffe M.B., Smerdon S.J. PhosphoSerine/threonine binding domains: you can't pSERious? Structure (Camb). 9:2001;R33-R38
46. Hart G.W., Greis K.D., Dong L.Y., Blomberg M.A., Chou T.Y., Jiang M.S., Roquemore E.P., Snow D.M., Kreppel L.K., Cole R.N., et al. O-linked N-acetylglucosamine: the "yin-yang" of Ser/Thr phosphorylation? Nuclear and cytoplasmic glycosylation. Adv. Exp. Med. Biol. 376:1995;115-123
47. Hart G.W., Kreppel L.K., Comer F.I., Arnold C.S., Snow D.M., Ye Z., Cheng X., DellaManna D., Caine D.S., Earles B.J., Akimoto Y., Cole R.N., Hayes B.K. O-GlcNAcylation of key nuclear and cytoskeletal proteins: reciprocity with O-phosphorylation and putative roles in protein multimerization. Glycobiology. 6:1996;711-716
48. Kelly W.G., Dahmus M.E., Hart G.W. RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc. J. Biol. Chem. 268:1993;10416-10424
49. Comer F.I., Hart G.W. Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II. Biochemistry. 40:2001;7845-7852
50. Medina L., Grove K., Haltiwanger R.S. SV40 large T antigen is modified with O-linked N-acetylglucosamine but not with other forms of glycosylation. Glycobiology. 8:1998;383-391
51. Chou T.Y., Dang C.V., Hart G.W. Glycosylation of the c-Myc transactivation domain. Proc. Natl. Acad. Sci. U. S. A. 92:1995;4417-4421
52. Chou T.Y., Hart G.W., Dang C.V. c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. J. Biol. Chem. 270:1995;18961-18965
53. T. Matsuoka, D. Dellamanna, J. Isaacs, J.A. Carroll, L.K. Kreppel, R.N. Cole, G.V.W. Johnsson, G.W. Hart (In preparation).
54. Comer F.I., Hart G.W. O-Glycosylation of nuclear and cytosolic proteins. Dynamic interplay between O-GlcNAc and O-phosphate. J. Biol. Chem. 275:2000;29179-29182
55. Lu K.P., Liou Y.C., Zhou X.Z. Pinning down proline-directed phosphorylation signaling. Trends Cell Biol. 12:2002;164-172
56. Lefebvre T., Alonso C., Mahboub S., Dupire M.J., Zanetta J.P., Caillet-Boudin M.L., Michalski J.C. Effect of okadaic acid on O-linked N-acetylglucosamine levels in a neuroblastoma cell line. Biochim. Biophys. Acta. 1472:1999;71-81
57. Lefebvre T., Ferreira S., Dupont-Wallois L., Bussiere T., Dupire M.J., Delacourte A., Michalski J.C., Caillet-Boudin M.L. Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins - a role in nuclear localization. Biochim. Biophys. Acta. 1619:2003;167-176
58. Griffith L.S., Schmitz B. O-linked N-acetylglucosamine levels in cerebellar neurons respond reciprocally to pertubations of phosphorylation. Eur. J. Biochem. 262:1999;824-831
59. Griffith L.S., Mathes M., Schmitz B. Beta-amyloid precursor protein is modified with O-linked N-acetylglucosamine. J. Neurosci. Res. 41:1995;270-278
60. O'Donnell N., Zachara N.E., Hart G.W., Marth J.D. OGT-dependent X-chromosome-linked intracellular protein glycosylation is essential for mammalian viability and cellular metabolism. Mol. Cell. Biol. 24:2004;1680-1690
61. Boehmelt G., Wakeham A., Elia A., Sasaki T., Plyte S., Potter J., Yang Y., Tsang E., Ruland J., Iscove N.N., Dennis J.W., Mak T.W. Decreased UDP-GlcNAc levels abrogate proliferation control in EMeg32-deficient cells. EMBO J. 19:2000;5092-5104
62. L. Wells, L.K. Kreppel, F.I. Comer, B.E. Wadzinski, G.W. Hart, A Functional yin-yang complex: O-GlcNAc transferase is associated with protein phosphatase 1 (Submitted for publication).
63. Comer F.I., Vosseller K., Wells L., Accavitti M.A., Hart G.W. Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine. Anal. Biochem. 293:2001;169-177
64. Vocadlo D.J., Hang H.C., Kim E.J., Hanover J.A., Bertozzi C.R. A chemical approach for identifying O-GlcNAc-modified proteins in cells. Proc. Natl. Acad. Sci. U. S. A. 100:2003;9116-9121
65. Vosseller K., Wells L., Lane M.D., Hart G.W. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. U. S. A. 99:2002;5313-5318
66. Haynes P.A., Aebersold R. Simultaneous detection and identification of O-GlcNAc-modified glycoproteins using liquid chromatography-tandem mass spectrometry. Anal. Chem. 72:2000;5402-5410
67. Chalkley R.J., Burlingame A.L. Identification of novel sites of O-N-acetylglucosamine modification of serum response factor using quadrupole time-of-flight mass spectrometry. Mol. Cell. Proteomics. 2:2003;182-190
68. Forrest A.R., Ravasi T., Taylor D., Huber T., Hume D.A., Grimmond S. Phosphoregulators: protein kinases and protein phosphatases of mouse. Genome Res. 13:2003;1443-1454
69. Manning G., Whyte D.B., Martinez R., Hunter T., Sudarsanam S. The protein kinase complement of the human genome. Science. 298:2002;1912-1934
70. Haltiwanger R.S., Blomberg M.A., Hart G.W. Glycosylation of nuclear and cytoplasmic proteins. Purification and characterization of a uridine diphospho-N-acetylglucosamine: polypeptide beta-N-acetylglucosaminyltransferase. J. Biol. Chem. 267:1992;9005-9013
71. Haltiwanger R.S., Holt G.D., Hart G.W. Enzymatic addition of O-GlcNAc to nuclear and cytoplasmic proteins. Identification of a uridine diphospho-N-acetylglucosamine:peptide beta-N-acetylglucosaminyltransferase. J. Biol. Chem. 265:1990;2563-2568
72. Kreppel L.K., Blomberg M.A., Hart G.W. Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats. J. Biol. Chem. 272:1997;9308-9315
73. Lubas W.A., Frank D.W., Krause M., Hanover J.A. O-Linked GlcNAc transferase is a conserved nucleocytoplasmic protein containing tetratricopeptide repeats. J. Biol. Chem. 272:1997;9316-9324
74. Gao Y., Wells L., Comer F.I., Parker G.J., Hart G.W. Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain. J. Biol. Chem. 276:2001;9838-9845
75. Wells L., Gao Y., Mahoney J.A., Vosseller K., Chen C., Rosen A., Hart G.W. Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic beta-N-acetylglucosaminidase O-GlcNAcase. J. Biol. Chem. 277:2002;1755-1761
76. Hartweck L.M., Scott C.L., Olszewski N.E. Two O-linked N-acetylglucosamine transferase genes of Arabidopsis thaliana L. Heynh. have overlapping functions necessary for gamete and seed development. Genetics. 161:2002;1279-1291
77. Okuyama R., Marshall S. UDP-N-acetylglucosaminyl transferase (OGT) in brain tissue: temperature sensitivity and subcellular distribution of cytosolic and nuclear enzyme. J. Neurochem. 86:2003;1271-1280
78. Nolte D., Muller U. Human O-GlcNAc transferase (OGT): genomic structure, analysis of splice variants, fine mapping in Xq13.1. Mamm. Genome. 13:2002;62-64
79. Hanover J.A., Yu S., Lubas W.B., Shin S.H., Ragano-Caracciola M., Kochran J., Love D.C. Mitochondrial and nucleocytoplasmic isoforms of O-linked GlcNAc transferase encoded by a single mammalian gene. Arch. Biochem. Biophys. 409:2003;287-297
80. Wrabl J.O., Grishin N.V. Homology between O-linked GlcNAc transferases and proteins of the glycogen phosphorylase superfamily. J. Mol. Biol. 314:2001;365-374
81. Blatch G.L., Lassle M. The tetratricopeptide repeat: a structural motif mediating protein-protein interactions. BioEssays. 21:1999;932-939
82. Iyer S.P., Akimoto Y., Hart G.W. Identification and cloning of a novel family of coiled-coil domain proteins that interact with O-GlcNAc transferase. J. Biol. Chem. 278:2003;5399-5409
83. Yang X., Zhang F., Kudlow J.E. Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: coupling protein O-GlcNAcylation to transcriptional repression. Cell. 110:2002;69-80
84. Beck M., Brickley K., Wilkinson H.L., Sharma S., Smith M., Chazot P.L., Pollard S., Stephenson F.A. Identification, molecular cloning, and characterization of a novel GABAA receptor-associated protein, GRIF-1. J. Biol. Chem. 277:2002;30079-30090
85. Iyer S.P., Hart G.W. Roles of the tetratricopeptide repeat domain in O-GlcNAc transferase targeting and protein substrate specificity. J. Biol. Chem. 278:2003;24608-24616
86. Kreppel L.K., Hart G.W. Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats. J. Biol. Chem. 274:1999;32015-32022
87. Lubas W.A., Hanover J.A. Functional expression of O-linked GlcNAc transferase. Domain structure and substrate specificity. J. Biol. Chem. 275:2000;10983-10988
88. McClain D.A. Hexosamines as mediators of nutrient sensing and regulation in diabetes. J. Diabetes Complicat. 16:2002;72-80
89. Bley R.L., Okubo H., Chandler A.M. Regulation of glucosamine synthesis in injury and partial hepatectomy. Proc. Soc. Exp. Biol. Med. 144:1973;134-140
90. Okubo H., Chandler A.M. Endocrine status and the response of glucosamine-6-phosphate synthetase to trauma. Exp. Mol. Pathol. 24:1976;91-104
91. Okubo H., Chandler A.M. Regulation of glucosamine synthesis during the first twenty-four hours following injury and partial hepatectomy. Proc. Soc. Exp. Biol. Med. 146:1974;1159-1162
92. Okubo H., Shibata K., Ishibashi H., Yanase T. Developmental studies on glucosamine metabolism. Proc. Soc. Exp. Biol. Med. 152:1976;626-630
93. Wice B.M., Trugnan G., Pinto M., Rousset M., Chevalier G., Dussaulx E., Lacroix B., Zweibaum A. The intracellular accumulation of UDP-N- acetylhexosamines is concomitant with the inability of human colon cancer cells to differentiate. J. Biol. Chem. 260:1985;139-146
94. Zhivkov V., Tosheva R., Zhivkova Y. Concentration of uridine diphosphate sugars in various tissues of vertebrates. Comp. Biochem. Physiol., B. 51:1975;421-424
95. Buse M.G., Robinson K.A., Gettys T.W., McMahon E.G., Gulve E.A. Increased activity of the hexosamine synthesis pathway in muscles of insulin-resistant ob/ob mice. Am. J. Physiol. 272:1997;E1080-E1088
96. Hawkins M., Angelov I., Liu R., Barzilai N., Rossetti L. The tissue concentration of UDP-N-acetylglucosamine modulates the stimulatory effect of insulin on skeletal muscle glucose uptake. J. Biol. Chem. 272:1997;4889-4895
97. Marshall S., Duong T., Orbus R.J., Rumberger J.M., Okuyama R. Measurement of UDP-N-acetylglucosaminyl transferase (OGT) in brain cytosol and characterization of anti-OGT antibodies. Anal. Biochem. 314:2003;169-179
98. McClain D.A., Lubas W.A., Cooksey R.C., Hazel M., Parker G.J., Love D.C., Hanover J.A. Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia. Proc. Natl. Acad. Sci. U. S. A. 99:2002;10695-10699
99. Konrad R.J., Zhang F., Hale J.E., Knierman M.D., Becker G.W., Kudlow J.E. Alloxan is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase. Biochem. Biophys. Res. Commun. 293:2002;207-212
100. Delannoy P., Kim I., Emery N., De Bolos C., Verbert A., Degand P., Huet G. Benzyl-N-acetyl-alpha-D-galactosaminide inhibits the sialylation and the secretion of mucins by a mucin secreting HT-29 cell subpopulation. Glycoconj. J. 13:1996;717-726
101. Huet G., Hennebicq-Reig S., de Bolos C., Ulloa F., Lesuffleur T., Barbat A., Carriere V., Kim I., Real F.X., Delannoy P., Zweibaum A. GalNAc-alpha-O-benzyl inhibits NeuAcalpha2-3 glycosylation and blocks the intracellular transport of apical glycoproteins and mucus in differentiated HT-29 cells. J. Cell. Biol. 141:1998;1311-1322
102. Fiordaliso F., Leri A., Cesselli D., Limana F., Safai B., Nadal-Ginard B., Anversa P., Kajstura J. Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes. 50:2001;2363-2375
103. James L.R., Tang D., Ingram A., Ly H., Thai K., Cai L., Scholey J.W. Flux through the hexosamine pathway is a determinant of nuclear factor kappaB-dependent promoter activation. Diabetes. 51:2002;1146-1156
104. Braidman I., Carroll M., Dance N., Robinson D., Poenaru L., Weber A., Dreyfus J.C., Overdijk B., Hooghwinkel G.J. Characterisation of human N-acetyl-beta-hexosaminidase C. FEBS Lett. 41:1974;181-184
105. Overdijk B., Van der Kroef W.M., Van Steijn G.J., Lisman J.J. Isolation and further characterization of bovine brain hexosaminidase C. Biochim. Biophys. Acta. 659:1981;255-266
106. Horsch M., Hoesch L., Vasella A., Rast D.M. N-acetylglucosaminono-1, 5-lactone oxime and the corresponding (phenylcarbamoyl)oxime. Novel and potent inhibitors of beta-N-acetylglucosaminidase. Eur. J. Biochem. 197:1991;815-818
107. Heckel D., Comtesse N., Brass N., Blin N., Zang K.D., Meese E. Novel immunogenic antigen homologous to hyaluronidase in meningioma. Hum. Mol. Genet. 7:1998;1859-1872
108. Comtesse N., Maldener E., Meese E. Identification of a nuclear variant of MGEA5, a cytoplasmic hyaluronidase and a beta-N-acetylglucosaminidase. Biochem. Biophys. Res. Commun. 283:2001;634-640
109. Schultz J., Pils B. Prediction of structure and functional residues for O-GlcNAcase, a divergent homologue of acetyltransferases. FEBS Lett. 529:2002;179-182
110. Snow C.M., Shaper J.H., Shaper N.L., Hart G.W. Mol. Biol. Cell. 6:1996;357
111. Snow D.M., Shaper J.H., Shaper N.L., Hart G.W. Determination of beta1, 4-galactosyltransferase enzymatic activity by capillary electrophoresis and laser-induced fluorescence detection. Anal. Biochem. 271:1999;36-42
112. Fang B., Miller M.W. Use of galactosyltransferase to assess the biological function of O-linked N-acetyl-d-glucosamine: a potential role for O-GlcNAc during cell division. Exp. Cell Res. 263:2001;243-253
113. Haltiwanger R.S., Grove K., Philipsberg G.A. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy- D-glucopyranosylidene)amino-N-phenylcarbamate. J. Biol. Chem. 273:1998;3611-3617
114. Franke T.F., Hornik C.P., Segev L., Shostak G.A., Sugimoto C. PI3K/Akt and apoptosis: size matters. Oncogene. 22:2003;8983-8998
115. Shafi R., Iyer S.P., Ellies L.G., O'Donnell N., Marek K.W., Chui D., Hart G.W., Marth J.D. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc. Natl. Acad. Sci. U. S. A. 97:2000;5735-5739
116. Boumil R.M., Lee J.T. Forty years of decoding the silence in X-chromosome inactivation. Hum. Mol. Genet. 10:2001;2225-2232
117. Buse M.G., Robinson K.A., Marshall B.A., Hresko R.C., Mueckler M.M. Enhanced O-GlcNAc protein modification is associated with insulin resistance in GLUT1-overexpressing muscles. Am. J. Physiol.: Endocrinol. Metab. 283:2002;E241-E250
118. Konrad R.J., Janowski K.M., Kudlow J.E. Glucose and streptozotocin stimulate p135 O-glycosylation in pancreatic islets. Biochem. Biophys. Res. Commun. 267:2000;26-32
119. Han I., Oh E.S., Kudlow J.E. Responsiveness of the state of O-linked N-acetylglucosamine modification of nuclear pore protein p62 to the extracellular glucose concentration. Biochem. J. 350(Pt. 1):2000;109-114
120. Yki-Jarvinen H., Virkamaki A., Daniels M.C., McClain D., Gottschalk W.K. Insulin and glucosamine infusions increase O-linked N-acetyl-glucosamine in skeletal muscle proteins in vivo. Metabolism. 47:1998;449-455
121. Du X.L., Edelstein D., Rossetti L., Fantus I.G., Goldberg H., Ziyadeh F., Wu J., Brownlee M. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc. Natl. Acad. Sci. U. S. A. 97:2000;12222-12226
122. Hawkins M., Barzilai N., Liu R., Hu M., Chen W., Rossetti L. Role of the glucosamine pathway in fat-induced insulin resistance. J. Clin. Invest. 99:1997;2173-2182
123. Wells L., Vosseller K., Hart G.W. A role for N-acetylglucosamine as a nutrient sensor and mediator of insulin resistance. Cell. Mol. Life Sci. 60:2003;222-228
124. Wells L., Whalen S.A., Hart G.W. O-GlcNAc: a regulatory post-translational modification. Biochem. Biophys. Res. Commun. 302:2003;435-441
125. McDaniel M.L., Marshall C.A., Pappan K.L., Kwon G. Metabolic and autocrine regulation of the mammalian target of rapamycin by pancreatic beta-cells. Diabetes. 51:2002;2877-2885
126. Whiteman E.L., Cho H., Birnbaum M.J. Role of Akt/protein kinase B in metabolism. Trends Endocrinol. Metab. 13:2002;444-451
127. Hardie D.G., Scott J.W., Pan D.A., Hudson E.R. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett. 546:2003;113-120
128. Goldberg H.J., Whiteside C.I., Fantus I.G. The hexosamine pathway regulates the plasminogen activator inhibitor-1 gene promoter and Sp1 transcriptional activation through protein kinase C-beta I and -delta. J. Biol. Chem. 277:2002;33833-33841
129. Jackson S.P., Tjian R. Purification and analysis of RNA polymerase II transcription factors by using wheat germ agglutinin affinity chromatography. Proc. Natl. Acad. Sci. U. S. A. 86:1989;1781-1785
130. Majumdar G., Harmon A., Candelaria R., Martinez-Hernandez A., Raghow R., Solomon S.S. O-glycosylation of Sp1 and transcriptional regulation of the calmodulin gene by insulin and glucagon. Am. J. Physiol.: Endocrinol. Metab. 285:2003;E584-E591
131. Weigert C., Klopfer K., Kausch C., Brodbeck K., Stumvoll M., Haring H.U., Schleicher E.D. Palmitate-induced activation of the hexosamine pathway in human myotubes: increased expression of glutamine: fructose-6-phosphate aminotransferase. Diabetes. 52:2003;650-656
132. McClain D.A., Paterson A.J., Roos M.D., Wei X., Kudlow J.E. Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. Proc. Natl. Acad. Sci. U. S. A. 89:1992;8150-8154
133. Roos M.D., Han I.O., Paterson A.J., Kudlow J.E. Role of glucosamine synthesis in the stimulation of TGF-alpha gene transcription by glucose and EGF. Am. J. Physiol. 270:1996;C803-C811
134. Robinson L.J., Razzack Z.F., Lawrence J.C. Jr., James D.E. Mitogen-activated protein kinase activation is not sufficient for stimulation of glucose transport or glycogen synthase in 3T3-L1 adipocytes. J. Biol. Chem. 268:1993;26422-26427
135. Hall J.L., Matter C.M., Wang X., Gibbons G.H. Hyperglycemia inhibits vascular smooth muscle cell apoptosis through a protein kinase C-dependent pathway. Circ. Res. 87:2000;574-580
136. Clark R.J., McDonough P.M., Swanson E., Trost S.U., Suzuki M., Fukuda M., Dillmann W.H. Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation. J. Biol. Chem. 278:2003;44230-44237
137. Jackson S.P., Tjian R. O-glycosylation of eukaryotic transcription factors: implications for mechanisms of transcriptional regulation. Cell. 55:1988;125-133
138. Roos M.D., Xie W., Su K., Clark J.A., Yang X., Chin E., Paterson A.J., Kudlow J.E. Streptozotocin, an analog of N-acetylglucosamine, blocks the removal of O-GlcNAc from intracellular proteins. Proc. Assoc. Am. Physicians. 110:1998;422-432
139. Sumegi M., Hunyadi-Gulyas E., Medzihradszky K.F., Udvardy A. 26S proteasome subunits are O-linked N-acetylglucosamine-modified in Drosophila melanogaster. Biochem. Biophys. Res. Commun. 312:2003;1284-1289
140. Zhang F., Su K., Yang X., Bowe D.B., Paterson A.J., Kudlow J.E. O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell. 115:2003;715-725
141. Hawkins M., Barzilai N., Chen W., Angelov I., Hu M., Cohen P., Rossetti L. Increased hexosamine availability similarly impairs the action of insulin and IGF-1 on glucose disposal. Diabetes. 45:1996;1734-1743
142. McClain D.A., Crook E.D. Hexosamines and insulin resistance. Diabetes. 45:1996;1003-1009
143. Marshall S., Bacote V., Traxinger R.R. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J. Biol. Chem. 266:1991;4706-4712
144. Robinson K.A., Sens D.A., Buse M.G. Pre-exposure to glucosamine induces insulin resistance of glucose transport and glycogen synthesis in isolated rat skeletal muscles. Study of mechanisms in muscle and in rat-1 fibroblasts overexpressing the human insulin receptor. Diabetes. 42:1993;1333-1346
145. Patti M.E., Virkamaki A., Landaker E.J., Kahn C.R., Yki-Jarvinen H. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. Diabetes. 48:1999;1562-1571
146. Nelson B.A., Robinson K.A., Buse M.G. High glucose and glucosamine induce insulin resistance via different mechanisms in 3T3-L1 adipocytes. Diabetes. 49:2000;981-991
147. Nakamura M., Barber A.J., Antonetti D.A., LaNoue K.F., Robinson K.A., Buse M.G., Gardner T.W. Excessive hexosamines block the neuroprotective effect of insulin and induce apoptosis in retinal neurons. J. Biol. Chem. 276:2001;43748-43755
148. Evans J.L., Goldfine I.D., Maddux B.A., Grodsky G.M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr. Rev. 23:2002;599-622
149. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 414:2001;813-820
150. Du X., Matsumura T., Edelstein D., Rossetti L., Zsengeller Z., Szabo C., Brownlee M. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J. Clin. Invest. 112:2003;1049-1057
151. Akimoto Y., Kawakami H., Yamamoto K., Munetomo E., Hida T., Hirano H. Elevated Expression of O-GlcNAc-Modified Proteins and O-GlcNAc transferase in corneas of diabetic Goto-Kakizaki rats. Invest. Ophthalmol. Vis. Sci. 44:2003;3802-3809
152. Ido Y., Carling D., Ruderman N. Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation. Diabetes. 51:2002;159-167
153. Liu K., Paterson A.J., Chin E., Kudlow J.E. Glucose stimulates protein modification by O-linked GlcNAc in pancreatic beta cells: linkage of O-linked GlcNAc to beta cell death. Proc. Natl. Acad. Sci. U. S. A. 97:2000;2820-2825
154. Konrad R.J., Kudlow J.E. The role of O-linked protein glycosylation in beta-cell dysfunction. Int. J. Mol. Med. 10:2002;535-539
155. Konrad R.J., Mikolaenko I., Tolar J.F., Liu K., Kudlow J.E. The potential mechanism of the diabetogenic action of streptozotocin: inhibition of pancreatic beta-cell O-GlcNAc-selective N-acetyl-beta-D-glucosaminidase. Biochem. J. 356:2001;31-41
156. Gao Y., Parker G.J., Hart G.W. Streptozotocin-induced beta-cell death is independent of its inhibition of O-GlcNAcase in pancreatic Min6 cells. Arch. Biochem. Biophys. 383:2000;296-302
157. Okuyama R., Yachi M. Cytosolic O-GlcNAc accumulation is not involved in beta-cell death in HIT-T15 or Min6. Biochem. Biophys. Res. Commun. 287:2001;366-371
158. Pasternak C.A., Aiyathurai J.E., Makinde V., Davies A., Baldwin S.A., Konieczko E.M., Widnell C.C. Regulation of glucose uptake by stressed cells. J. Cell. Physiol. 149:1991;324-331
159. Sviderskaya E.V., Jazrawi E., Baldwin S.A., Widnell C.C., Pasternak C.A. Cellular stress causes accumulation of the glucose transporter at the surface of cells independently of their insulin sensitivity. J. Membr. Biol. 149:1996;133-140
160. Warren A.P., James M.H., Menzies D.E., Widnell C.C., Whitaker-Dowling P.A., Pasternak C.A. Stress induces an increased hexose uptake in cultured cells. J. Cell. Physiol. 128:1986;383-388
161. Widnell C.C., Baldwin S.A., Davies A., Martin S., Pasternak C.A. Cellular stress induces a redistribution of the glucose transporter. FASEB J. 4:1990;1634-1637
162. Ikari A., Nakano M., Kawano K., Suketa Y. Up-regulation of sodium-dependent glucose transporter by interaction with heat shock protein 70. J. Biol. Chem. 277:2002;33338-33343
163. Barnes K., Ingram J.C., Porras O.H., Barros L.F., Hudson E.R., Fryer L.G., Foufelle F., Carling D., Hardie D.G., Baldwin S.A. Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMP-activated protein kinase (AMPK). J. Cell. Sci. 115:2002;2433-2442
164. Moley K.H., Mueckler M.M. Glucose transport and apoptosis. Apoptosis. 5:2000;99-105
165. Lin Z., Weinberg J.M., Malhotra R., Merritt S.E., Holzman L.B., Brosius F.C. III GLUT-1 reduces hypoxia-induced apoptosis and JNK pathway activation. Am. J. Physiol.: Endocrinol. Metab. 278:2000;E958-E966
166. Malhotra R., Brosius F.C. III Glucose uptake and glycolysis reduce hypoxia-induced apoptosis in cultured neonatal rat cardiac myocytes. J. Biol. Chem. 274:1999;12567-12575
167. Dwyer D.S., Liu Y., Bradley R.J. An ethanol-sensitive variant of the PC12 neuronal cell line: sensitivity to alcohol is associated with increased cell adhesion and decreased glucose accumulation. J. Cell. Physiol. 178:1999;93-101
168. Fiorentini D., Hakim G., Bonsi L., Bagnara G.P., Maraldi T., Landi L. Acute regulation of glucose transport in a human megakaryocytic cell line: difference between growth factors and H(2)O(2). Free Radic. Biol. Med. 31:2001;923-931
169. Kozlovsky N., Rudich A., Potashnik R., Ebina Y., Murakami T., Bashan N. Transcriptional activation of the Glut1 gene in response to oxidative stress in L6 myotubes. J. Biol. Chem. 272:1997;33367-33372
170. Barros L.F., Barnes K., Ingram J.C., Castro J., Porras O.H., Baldwin S.A. Hyperosmotic shock induces both activation and translocation of glucose transporters in mammalian cells. Pflügers Arch. 442:2001;614-621
171. Zhang J.Z., Behrooz A., Ismail-Beigi F. Regulation of glucose transport by hypoxia. Am. J. Kidney Dis. 34:1999;189-202
172. Berridge M.V., Tan A.S., McCoy K.D., Kansara M., Rudert F. CD95 (Fas/Apo-1)-induced apoptosis results in loss of glucose transporter function. J. Immunol. 156:1996;4092-4099
173. Kan O., Baldwin S.A., Whetton A.D. Apoptosis is regulated by the rate of glucose transport in an interleukin 3 dependent cell line. J. Exp. Med. 180:1994;917-923
174. Liu W., Schoenkerman A., Lowe W.L. Jr. Activation of members of the mitogen-activated protein kinase family by glucose in endothelial cells. Am. J. Physiol.: Endocrinol. Metab. 279:2000;E782-E790
175. Pang Y., Hunton D.L., Bounelis P., Marchase R.B. Hyperglycemia inhibits capacitative calcium entry and hypertrophy in neonatal cardiomyocytes. Diabetes. 51:2002;3461-3467
176. 2+ influx in rat aortic smooth muscle cells. Am. J. Physiol. 269:1995;C1482-C1488
177. Vemuri S., Marchase R.B. The inhibition of capacitative calcium entry due to ATP depletion but not due to glucosamine is reversed by staurosporine. J. Biol. Chem. 274:1999;20165-20170
178. Zachara N.E., O'Donnell N., Cheung W.D., Mercer J., Marth J.D., Hart G.W. Dynamic O-GlcNAc modification of Nucleocytoplasmic proteins in response to stress: A survival response of mammalian cells. J. Biol. Chem. 2004
179. Mer G., Hietter H., Lefevre J.F. Stabilization of proteins by glycosylation examined by NMR analysis of a fucosylated proteinase inhibitor. Nat. Struct. Biol. 3:1996;45-53
180. Roquemore E.P., Dell A., Morris H.R., Panico M., Reason A.J., Savoy L.A., Wistow G.J., Zigler J.S. Jr., Earles B.J., Hart G.W. Vertebrate lens alpha-crystallins are modified by O-linked N-acetylglucosamine. J. Biol. Chem. 267:1992;555-563
181. Soti C., Csermely P. Chaperones and aging: role in neurodegeneration and in other civilizational diseases. Neurochem. Int. 41:2002;383-389
182. Soti C., Csermely P. Molecular chaperones and the aging process. Biogerontology. 1:2000;225-233
183. Arnold C.S., Johnson G.V., Cole R.N., Dong D.L., Lee M., Hart G.W. The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine. J. Biol. Chem. 271:1996;28741-28744
184. Muller U., Steinberger D., Nemeth A.H. Clinical and molecular genetics of primary dystonias. Neurogenetics. 1:1998;165-177
185. Farook V.S., Bogardus C., Prochazka M. Analysis of MGEA5 on 10q24.1-q24.3 encoding the beta-O-linked N-acetylglucosaminidase as a candidate gene for type 2 diabetes mellitus in Pima Indians. Mol. Genet. Metab. 77:2002;189-193
186. Li Y.J., Scott W.K., Hedges D.J., Zhang F., Gaskell P.C., Nance M.A., Watts R.L., Hubble J.P., Koller W.C., Pahwa R., Stern M.B., Hiner B.C., Jankovic J., Allen F.A. Jr., Goetz C.G., Mastaglia F., Stajich J.M., Gibson R.A., Middleton L.T., Saunders A.M., Scott B.L., Small G.W., Nicodemus K.K., Reed A.D., Schmechel D.E., Welsh-Bohmer K.A., Conneally P.M., Roses A.D., Gilbert J.R., Vance J.M., Haines J.L., Pericak-Vance M.A. Age at onset in two common neurodegenerative diseases is genetically controlled. Am. J. Hum. Genet. 70:2002;985-993
187. Hoyer S. The aging brain. Changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). A mini-review. J. Neural Transm. 109:2002;991-1002
188. Patel J.R., Brewer G.J. Age-related changes in neuronal glucose uptake in response to glutamate and beta-amyloid. J. Neurosci. Res. 72:2003;527-536
189. Gual P., Gonzalez T., Gremeaux T., Barres R., Le Marchand-Brustel Y., Tanti J.F. Hyperosmotic stress inhibits insulin receptor substrate-1 function by distinct mechanisms in 3T3-L1 adipocytes. J. Biol. Chem. 278:2003;26550-26557
190. Yokoyama K., Fukumoto K., Murakami T., Harada S., Hosono R., Wadhwa R., Mitsui Y., Ohkuma S. Extended longevity of Caenorhabditis elegans by knocking in extra copies of hsp70F, a homolog of mot-2 (mortalin)/mthsp70/Grp75. FEBS Lett. 516:2002;53-57
191. Liu K., Paterson A.J., Konrad R.J., Parlow A.F., Jimi S., Roh M., Chin E. Jr., Kudlow J.E. Streptozotocin, an O-GlcNAcase inhibitor, blunts insulin and growth hormone secretion. Mol. Cell. Endocrinol. 194:2002;135-146
192. Carmeliet P., Dor Y., Herbert J.M., Fukumura D., Brusselmans K., Dewerchin M., Neeman M., Bono F., Abramovitch R., Maxwell P., Koch C.J., Ratcliffe P., Moons L., Jain R.K., Collen D., Keshert E., Keshet E. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 394:1998;485-490
193. Moley K.H., Chi M.M., Knudson C.M., Korsmeyer S.J., Mueckler M.M. Hyperglycemia induces apoptosis in pre-implantation embryos through cell death effector pathways. Nat. Med. 4:1998;1421-1424
194. Moley K.H., Chi M.M., Mueckler M.M. Maternal hyperglycemia alters glucose transport and utilization in mouse preimplantation embryos. Am. J. Physiol. 275:1998;E38-E47
195. Pereira C., Moreira P., Seica R., Santos M.S., Oliveira C.R. Susceptibility to beta-amyloid-induced toxicity is decreased in Goto-Kakizaki diabetic rats: involvement of oxidative stress. Exp. Neurol. 161:2000;383-391
196. Holzenberger M., Dupont J., Ducos B., Leneuve P., Geloen A., Even P.C., Cervera P., Le Bouc Y. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature. 421:2003;182-187
197. Sukegawa J., Blobel G. A nuclear pore complex protein that contains zinc finger motifs, binds DNA, and faces the nucleoplasm. Cell. 72:1993;29-38
198. Lichtsteiner S., Schibler U. A glycosylated liver-specific transcription factor stimulates transcription of the albumin gene. Cell. 57:1989;1179-1187
199. Privalsky M.L. A subpopulation of the avian erythroblastosis virus v-erbA protein, a member of the nuclear hormone receptor family, is glycosylated. J. Virol. 64:1990;463-466
200. Sommer L., Hagenbuchle O., Wellauer P.K., Strubin M. Nuclear targeting of the transcription factor PTF1 is mediated by a protein subunit that does not bind to the PTF1 cognate sequence. Cell. 67:1991;987-994
201. Reason A.J., Morris H.R., Panico M., Marais R., Treisman R.H., Haltiwanger R.S., Hart G.W., Kelly W.G., Dell A. Localization of O-GlcNAc modification on the serum response transcription factor. J. Biol. Chem. 267:1992;16911-16921
202. Shaw P., Freeman J., Bovey R., Iggo R. Regulation of specific DNA binding by p53: evidence for a role for O-glycosylation and charged residues at the carboxy-terminus. Oncogene. 12:1996;921-930
203. Cheng X., Hart G.W. Alternative O-glycosylation/O-phosphorylation of serine-16 in murine estrogen receptor beta: post-translational regulation of turnover and transactivation activity. J. Biol. Chem. 276:2001;10570-10575
204. Cheng X., Hart G.W. Glycosylation of the murine estrogen receptor-alpha. J. Steroid Biochem. Mol. Biol. 75:2000;147-158
205. Jiang M.S., Hart G.W. A subpopulation of estrogen receptors are modified by O-linked N-acetylglucosamine. J. Biol. Chem. 272:1997;2421-2428
206. Zhu W., Leber B., Andrews D.W. Cytoplasmic O-glycosylation prevents cell surface transport of E-cadherin during apoptosis. EMBO J. 20:2001;5999-6007
207. Lefebvre T., Planque N., Leleu D., Bailly M., Caillet-Boudin M.L., Saule S., Michalski J.C. O-glycosylation of the nuclear forms of Pax-6 products in quail neuroretina cells. J. Cell. Biochem. 85:2002;208-218
208. Hatsell S.J., Medina L., Merola J., Haltiwanger R., Cowin P. Plakoglobin is O-glycosylated close to the N-terminal destruction box. J. Biol. Chem. 278:2003;37745-37752
209. Hiromura M., Choi C.H., Sabourin N.A., Jones H., Bachvarov D., Usheva A. YY1 is regulated by O-linked N-acetylglucosaminylation (O-GlcNAcylation). J. Biol. Chem. 278:2003;14046-14052
210. Lamarre-Vincent N., Hsieh-Wilson L.C. Dynamic glycosylation of the transcription factor CREB: a potential role in gene regulation. J. Am. Chem. Soc. 125:2003;6612-6613
211. L. Wells, G.W. Hart, The E2F-1 associated retinoblastoma-susceptibility gene product is modified by O-GlcNAc (Submitted for publication).
212. Meikrantz W., Smith D.M., Sladicka M.M., Schlegel R.A. Nuclear localization of an O-glycosylated protein phosphotyrosine phosphatase from human cells. J. Cell. Sci. 98(Pt 3):1991;303-307
213. King I.A., Hounsell E.F. Cytokeratin 13 contains O-glycosidically linked N-acetylglucosamine residues. J. Biol. Chem. 264:1989;14022-14028
214. Dong D.L., Xu Z.S., Chevrier M.R., Cotter R.J., Clevel D.W., Hart G.W. Glycosylation of mammalian neurofilaments. Localization of multiple O-linked N-acetylglucosamine moieties on neurofilament polypeptides L and M. J. Biol. Chem. 268:1993;16679-16687
215. Dong D.L., Xu Z.S., Hart G.W., Cleveland D.W. Cytoplasmic O-GlcNAc modification of the head domain and the KSP repeat motif of the neurofilament protein neurofilament-H. J. Biol. Chem. 271:1996;20845-20852
216. Inaba M., Maede Y. O-N-acetyl-D-glucosamine moiety on discrete peptide of multiple protein 4.1 isoforms regulated by alternative pathways. J. Biol. Chem. 264:1989;18149-18155
217. Hagmann J., Grob M., Burger M.M. The cytoskeletal protein talin is O-glycosylated. J. Biol. Chem. 267:1992;14424-14428
218. G isoforms targeted to nodes of Ranvier. J. Biol. Chem. 271:1996;31391-31398
219. Cole R.N., Hart G.W. Glycosylation sites flank phosphorylation sites on synapsin I: O-linked N-acetylglucosamine residues are localized within domains mediating synapsin I interactions. J. Neurochem. 73:1999;418-428
220. Cole R.N., Hart G.W. Cytosolic O-glycosylation is abundant in nerve terminals. J. Neurochem. 79:2001;1080-1089
221. Pol-Rodriguez M.M., Schwartz G.A., English A.W. Post-translational phosphorylation of the slow/beta myosin heavy chain isoform in adult rabbit masseter muscle. J. Muscle Res. Cell Motil. 22:2001;513-519
222. Ding M., Vandre D.D. High molecular weight microtubule-associated proteins contain O-linked-N-acetylglucosamine. J. Biol. Chem. 271:1996;12555-12561
223. Caillet-Boudin M.L., Strecker G., Michalski J.C. O-linked GlcNAc in serotype-2 adenovirus fibre. Eur. J. Biochem. 184:1989;205-211
224. Mullis K.G., Haltiwanger R.S., Hart G.W., Marchase R.B., Engler J.A. Relative accessibility of N-acetylglucosamine in trimers of the adenovirus types 2 and 5 fiber proteins. J. Virol. 64:1990;5317-5323
225. Murphy J.E., Hanover J.A., Froehlich M., DuBois G., Keen J.H. Clathrin assembly protein AP-3 is phosphorylated and glycosylated on the 50-kDa structural domain. J. Biol. Chem. 269:1994;21346-21352
226. Yao P.J., Coleman P.D. Reduced O-glycosylated clathrin assembly protein AP180: implication for synaptic vesicle recycling dysfunction in Alzheimer's disease. Neurosci. Lett. 252:1998;33-36
227. Yao P.J., Coleman P.D. Reduction of O-linked N-acetylglucosamine-modified assembly protein-3 in Alzheimer's disease. J. Neurosci. 18:1998;2399-2411
228. Benko D.M., Gibson W. Primate cytomegalovirus glycoproteins: lectin-binding properties and sensitivities to glycosidases. J. Virol. 59:1986;703-713
229. Benko D.M., Haltiwanger R.S., Hart G.W., Gibson W. Virion basic phosphoprotein from human cytomegalovirus contains O-linked N-acetylglucosamine. Proc. Natl. Acad. Sci. U. S. A. 85:1988;2573-2577
230. Gonzalez S.A., Burrone O.R. Rotavirus NS26 is modified by addition of single O-linked residues of N-acetylglucosamine. Virology. 182:1991;8-16
231. Whitford M., Faulkner P. A structural polypeptide of the baculovirus Autographa californica nuclear polyhedrosis virus contains O-linked N-acetylglucosamine. J. Virol. 66:1992;3324-3329
232. Medina L., Haltiwanger R. Mol. Biol. Cell. 5(s):1994;340. (abstract)